GLTO

Galecto Inc

NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY

$24.16

-7.65% today

Updated 2026-06-02

Market cap

$43.73M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-12.11

Dividend yield

—

52W range

$2 – $38

Volume

0.3M

Market cap

$43.73M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-12.11

Dividend yield

—

52W range

$2 – $38

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$32.00

+32.45%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.62M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-51.75M	$-61.62M	$-38.35M	$-21.44M	$-3.13M
EPS	—	—	—	—	$-12.11
Free cash flow	$-52.53M	$-43.13M	$-36.99M	$-18.62M	$-2.62M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLTO	$43.73M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Galecto Inc trades at $24.16. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Galecto Inc's stock price?

Galecto Inc (GLTO) trades at $24.16.

Is Galecto Inc overvalued?

Galecto Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Galecto Inc (GLTO)?

The 12-month analyst consensus target is $32.00, about 32.5% above the current $24.16. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-1.10%

Beta1.41

50D MA$12.85

200D MA$5.73

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLTO vs LLY →GLTO vs JNJ →GLTO vs ABBV →Stock screener →